ArticleMedicine2026

Baseline predictors of early progression during EGFR-TKI therapy in patients with EGFR-mutant non-small cell lung cancer: A retrospective cohort study.

Xiaoyan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.